Nomura Singapore Ltd. picks up stake in BLS International Ltd

New Delhi [India], August 30: BLS International (BSE: 540073; NSE: BLS; MSE: BLS) is a trusted global tech-enabled services partner for governments and citizens. As per bulk deal data available on NSE, Global financial services firm Nomura Singapore Ltd. bought 11,00,000 shares of the company at an average price of Rs 230 apiece on 29 August 2022.

Earlier this month, the company had reported its Q1FY23 earnings. Operational Revenue stood at ₹ 272.8 crores in Q1 FY23, up by 52.8% from ₹ 178.5 crores in Q1 FY22. EBITDA stood at ₹ 31.5 crores in Q1 FY23, up from ₹ 18.8 crores in Q1 FY22. PBT was at ₹ 32.4 crores in Q1 FY23 compared to ₹ 20.8 crores in Q1 FY22. Profit After Tax (PAT) for the quarter stood at ₹ 30.7 crores compared to ₹ 20.3 crores in the same period of the last financial year. The company also Acquired Zero Mass Pvt. Ltd. (ZMPL). BLS acquired an 88.71% stake in ZMPL, making it the largest business correspondent (BC) for SBI across India.

BLS International Services Ltd. (“BLS International” or “BLS”) is a trusted global tech-enabled services partner for governments and citizens. It has an impeccable reputation for setting benchmarks in the domain of visa, passport, consular, citizen, e-governance, attestation, biometric, e-visa and retail services since 2005. The company is recognized as “India’s Most Valuable Companies” by Business Today Magazine, “Best under a Billion’ company” by Forbes Asia and ranked amongst “Fortune India’s Next 500 companies”.

The company works with over 46 client governments, including Diplomatic Missions, Embassies & Consulates, and leverages technology and processes that ensure data security. The company now has an extensive network of more than 15,500 centres globally with a robust strength of over 20,000 employees and associates that provides consular, biometrics and citizen services. BLS has processed over 62 million applications to date globally.

BLS International is the only listed company in this domain, with operations in 66 countries.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Comments are closed.

Business

Zeus Hygia Lifesciences Establishes US Subsidiary to Propel Nutraceutical Innovations

New Delhi [India], December 14: Started operations since 2018, founded by visionary entrepreneurs Arunkanth Krishnakumar and Shankaranarayanan, Zeus Hygia Lifesciences has rapidly ascended as one of India’s most innovative nutraceutical Ingredient companies. The company is now expanding its horizons, forming a US subsidiary to penetrate the North American market with its cutting-edge platform technologies and […]

Read More
Business

Deep Ayurveda plans nationwide network of Clinical operations, Distribution network in India/Australia

Mohali (Punjab) [India], December 14: Deep Ayurveda, a trusted name in Ayurvedic manufacturing and clinical operations, is set to launch State wise CFA. District wise Distributors, and also retailers, a chain of exclusive Ayurveda Retail Stores and Clinics across India. Initially, this expansion of Clinical Operations will focus on major metro areas and Tier A, B […]

Read More
Business

Unnati Venture India Invests in GRF, Advancing India’s Goal as a Global ADR Hub

New Delhi [India], December 13: In December 2024, Unnati Venture India announced a strategic investment in the Global Resolution Forum (GRF), India’s premier hybrid dispute resolution platform. This partnership is poised to strengthen GRF’s mission of transforming India into a global hub for Alternative Dispute Resolution (ADR) by leveraging advanced technology, progressive regulations, and unparalleled […]

Read More